Recombinant DNA Technology Market (By Product: Medical, Non-Medical; By Component: Expression System, Cloning Vector; By Application: Health and disease, Food and Agriculture, Environment, Others; By End User: Pharmaceutical and biotechnology companies, Research institutes, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global recombinant DNA technology market size was accounted at USD 690 billion in 2021 and is expected to surpass around USD 1079 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 5.09% during the forecast period 2022 to 2030.

  • North America accounted largest revenue share of around 51% in 2021
  • In 2021, Europe region garnered market share of around 24%

Recombinant DNA Technology Market Size 2022 To 2030


Recombinant DNA technology works on external alteration of the genetic material of a particular Organism In order to achieve the desired qualities or the characteristics by using a desirable sequence of the gene. There has been an increased use of this technology in improving the quality of the crops it is used in the manufacturing of various medicines and it also has many industrial applications. The use of this technology in the healthcare sector has provided many effective medicines for different types of illnesses. Insulin is produced by the use of this technology. by the way of introducing the gene of human insulin into the bacterial cells which helps in producing the insulin which is required for the diabetic patients is collected through the bacteria and distributed for medicinal purposes.

Recombinant DNA technology is also known as genetic engineering. Although there are a lot of benefits and the users of the recombinant DNA technology there are a few downfalls. As the genetics of the organisms are changed and they are introduced in the habitats it happens to be a reason for negatively hampering the original species existing in the environment. The use of this technology in manufacturing various medicines also has negative effects. crops grown with the use of this technology may lead to cross contamination and at times the weeds that have grown around these crops May grow in an uncontrolled fashion as they may be extremely hard to control. When a hybrid is created by using this technology there are a lot of ethical issues that come in play. Although this technology has been used in producing various hormones especially insulin but there are a few side effects like allergy due to the introduction of it into the individual.

During the pandemic there has been a growth in the recombinant DNA technology market. There was a growing demand for the use of this technology for the diagnosis and therapies. This technology was used in the research and development purposes for developing COVID-19 vaccination. Recombinant vaccines word developed in order to combat COVID-19 and these vaccines what expected to be effective and had lesser safety concerns as compared to the other vaccines. This technology was used widely in order to manufacture COVID-19 vaccination in the recent years. Astra Zeneca was the vaccine which was developed in the year 2020. This vaccination had received its approval in United Kingdom. Starting from January 2021 in a span of a year about 2.5 billion vaccines have been provided in 170 countries across the globe. This technology plays an extremely important part in the health care industry. Continuous research and development in this field has led to developing a lot of vaccines and pharmaceutical products.

Growth Factors

In order to develop different types of diseases acquired by plants and humans these genetically altered vaccinations proved to be extremely helpful in improving the health of the individuals by providing various vaccines and drugs. Apart from its use in the Pharmaceutical industry and the healthcare industry there has been a growth in the demand for this technology in the fuel industry. The use of microorganisms that are genetically modified in the production of clean fuel and the use of these microorganisms as bio degraders is expected to grow in the coming years. There has been an increased use of this technology in the development of a large variety of the therapeutic products. The use of this technology for modifying different plants and animals as well as microorganisms has been extremely helpful in yielding better substances. 

The recombinant DNA technology market is expected to grow in the coming years as there is a great demand for the use of this technology across many industries. It's used in the production of various types of grains and other crops are also expected to drive the market in the coming years. Genetically modified crops are one of the applications of the recombinant DNA technology. This technology is also used in the manufacturing of different types of bio pesticides that are extremely useful as compared to the already existing conventional products. As there has been an increase in the geriatric population across the globe leading to various chronic diseases the use of recombinant DNA technology in order to treat these product diseases has grown in the recent years. The use of this technology for the treatment of various chronic diseases has seemed to be extremely effective and therefore the market for this technology is expected to grow in the coming years. as various drugs and therapy is used for the treatment of these chronic diseases need an approval from the FDA there has been and increase in the demand for these drugs and therapies as it has helped in providing better safety for the consumers.

The market for the user of recombinant DNA technology is expected to grow with the highest compound annual growth rate in the North American region and the European region as there are better research facilities available in this area. These regions are expected to see good amount of growth opportunities in the future. The availability of good infrastructure for research and development purposes in this area also makes it extremely affordable for various tests. In order to have better opportunities for growth in the developing regions the major market players are also planning to enter into the developing nations.

Report Scope of the Recombinant DNA Technology Market

Report Coverage Details
Market Size in 2022 USD 725.14 Billion
Market Size by 2030

USD 1079 Billion

Growth Rate from 2022 to 2030 CAGR of 5.09%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Component, Application, End User, Geography
Companies Mentioned

Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc., Biogen, Inc., Merck & Co., Inc., Profacgen, Amgen, Inc., Monsanto Company


Product Insights

There has been a maximum use of the recombinant DNA technology in the pharmaceutical and medical field. This technology is used for treating many diseases in human beings by the way of replacing the old genes that are damaged with the new genes. Bluetooth increasing use in the clinical medicines the market is expected to grow well in the coming years. The medical segment is expected to have the largest market share in the coming years and it has dominated the market in the past. There has been a growth in the demand for various products that are genetically engineered for these healthcare or clinical purposes. 

Apart from the therapeutic purpose of this technology there is also a growth in the revenue which is generated through the vaccines. The market for genetically engineered vaccines is large. Apart from the use of this technology in the medical segment the crops segment is also expected to have a good amount of share in the coming years the non medical segment includes the production of various crops through the use of this technology. There has been a growth in the demand for genome editing which will drive the market growth in the coming years. the nations that make use of the biotech crops on a large scale are Canada, USA, India, Brazil as well as Argentina.

Components Insights

On the basis of components the expression system segment is expected to have a dominant position in the coming years. Due to an increase in the research and developmental activities related to the efficient protein expression the market is expected to grow well in the coming years. there has been a maximum use of the bacterial systems, insect and the mammalian systems. in the recent years there has also been a great amount of research in having the plant to be the expression system.

Application Insights

On the basis of application, the health and the disease application segment is expected to have the largest market share in the coming years period this segment has dominated the market in the past and it is expected to grow in the coming years. As there is been a great demand for various products that are manufactured through the use of this technology in this market the segment is expected to grow well even in the coming years these products are developed in order to treat different types of diseases in the human beings and providing vaccinations for the same. There has also been an increased use of this technology in the production of different enzymes that are used for replacement. 

Apart from the use of this technology in preventing and treating different diseases in the human beings it is also used in the treatment of various animals. The growth in the population across the developing as well as the developed nations has put a lot of burden on the agricultural industry. In order to have better yield and improved crops the farmers are adopting the use of this technology. The use of this recombination technique has provided great success in the food and agricultural industry. The use of this technology in the Food and Agriculture industry has improved the quality and the quantity of the yield which is expected to meet the demands of the growing population. It is also used in the manufacturing of biofuel. In the coming years the use of this technology in the production of biofuel is expected to grow significantly as they shall be a great demand for these types of fuels.

End User Insights

These companies are adopting the use of these technology is not order to improve their productivity of the drugs in terms of quality. The use of this technology in the manufacturing of various drugs is expected to have a great impact in the coming years. In order to provide better medicines for the therapeutic purposes there has been an increase in the investments made by various companies to provide better options to the consumers. 

Recombinant DNA Technology Market Share, By Region, 2021 (%)

Regions Revenue Share in 2021 (%)
North America 51%
Asia Pacific 15%
Europe 24%
Latin America 5.5%
MEA 4.5%


Geography Insights

The North American region is expected to have the largest market share due to the presence of for large number of manufacturing units present in the United States. Apart from the presence of various manufacturing units the existence of the regulatory bodies happens to be another driving factor for the growth of this market in the North American region. Increased investments and growing awareness regarding the benefits of this technology has provided great benefits.

Key market developments

CRISPR happens to be one of the recent solutions that have been helpful in providing relief from various problems of varied species. The solution has been developed for targeting the destruction the human genes.

Key market players

  • Pfizer
  • Sanofi
  • New England Biolabs
  • GlaxoSmithKline plc
  • GenScript
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Amgen, Inc.
  • Monsanto Company

Segments covered in the report

(Note*: We offer reports based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Medical
    • Therapeutic Agent
    • Human Protein
    • Vaccines
  • Non-Medical

By Component

  • Expression System
    • Mammalian
    • Bacteria
    • Yeast
    • Baculovirus/Insect
  • Cloning Vector

By Application

  • Health and disease
    • Human
    • Animal
  • Food and Agriculture
  • Environment
  • Others

By End User

  • Pharmaceutical and biotechnology companies
  • Research institutes
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of recombinant DNA technology market?
The global recombinant DNA technology market size was accounted at USD 690 billion in 2021 and it is expected to reach around USD 1079 billion by 2030.
The global recombinant DNA technology market is poised to grow at a CAGR of 5.09% from 2022 to 2030.
The major players operating in the recombinant DNA technology market are Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc., Biogen, Inc., Merck & Co., Inc., Profacgen, Amgen, Inc., Monsanto Company
Growing demand and good adoption of the biopesticides which are manufactured using the recombinant DNA technology and the use of genetically modified crops the market for recombinant DNA technology is expected to grow well in the coming years. Increased use of this technology for the treatment of the chronic diseases is also expected to drive the market growth in the coming years.
North America region will lead the global recombinant DNA technology market during the forecast period 2022 to 2030.
  • Report Code:1907
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample